BigHat Biosciences
BigHat Biosciences is a Series B biotech company based outside San Francisco, focused on developing safer and more effective antibody therapies using machine learning and synthetic biology. Their Milliner platform integrates a high-speed wet lab with advanced machine learning technologies for antibody discovery and engineering. With over $100 million raised from top investors, BigHat is positioned to tackle complex therapeutic challenges and has a pipeline of both wholly-owned and partnered programs.
BigHat Biosciences
BigHat Biosciences is a Series B biotech company based outside San Francisco, focused on developing safer and more effective antibody therapies using machine learning and synthetic biology. Their Milliner platform integrates a high-speed wet lab with advanced machine learning technologies for antibody discovery and engineering. With over $100 million raised from top investors, BigHat is positioned to tackle complex therapeutic challenges and has a pipeline of both wholly-owned and partnered programs.
